BioSpace News Archive

Versant Ventures Raises USD100 Million Canadian Fund

Versant Ventures today announced that it raised USD100 million for a Canadian fund called Versant Voyageurs I. Voyageurs will be deployed across five to eight startup companies with Canadian operations.

December 17, 2018
·
2 min read
Policy

EVIO Labs Receives Provisional License from Massachusetts Cannabis Control Commission

Independent testing laboratory in final phase to perform state compliance testing

December 17, 2018
·
3 min read
Business

BIONIK Laboratories Announces Multi-Year Purchase Agreement and Ongoing Relationship with Kindred Hospital Rehabilitation Services for InMotion Arm™ Robotic Systems

Multi-year commitment will place InMotion Arm™ Robots in existing and future Kindred Inpatient Rehabilitation Hospitals across the United States

December 17, 2018
·
5 min read
AmorChem Spins out Its Muco-Adhesive Nanoparticle Delivery Platform into MyX Therapeutics, with 450,000$ Seed Investment.

This capital will allow MyX to clinch its first deals with commercial partners, targeting primarily ocular diseases in both animal and human health.

December 17, 2018
·
3 min read
FDA

UroGen Pharma Initiates Rolling Submission of New Drug Application (NDA) for UGN-101 for the Treatment of Low-Grade Upper Tract Urothelial Cancer (LG UTUC)

UGN-101 Has the Potential to Become the First Drug Ever Approved for LG UTUC

December 17, 2018
·
4 min read
BioForest

Bardy Diagnostics™ Selected As Winner Of The Fierce Innovation Life Sciences Award

Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced today that it has been selected as a winner in the sixth annual Fierce Innovation Awards

December 17, 2018
·
4 min read
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)

The product is a biosimilar candidate of Perjeta® (pertuzumab) currently in preclinical development.

December 17, 2018
·
3 min read
Pharm Country

Bayer Updates Betaseron (interferon beta-1b) Prescribing Information in Accordance with the U.S. Food and Drug Administration’s Pregnancy and Lactation Labeling Rule

Bayer announced today that the Food and Drug Administration (FDA) has approved the inclusion of new safety data on pregnancy in the prescribing information for Betaseron® (Interferon beta 1b, IFNß-1b), which is indicated for the treatment of relapsing remitting multiple sclerosis (RRMS).

December 17, 2018
·
10 min read
Pharm Country

Balance 3H Plus Expands to New York City

Harrison-based Balance 3H Plus, a leading, doctor-supervised total health program that provides hormonal balance solutions for women 40 and older, has expanded to New York City.

December 17, 2018
·
3 min read
Business

East River BioSolutions Announces Rebrand to Xylyx Bio

Rebrand establishes Xylyx Bio as “The Cell Environment Company” and highlights focus on accelerating science for improved human health

December 17, 2018
·
2 min read